Toru Okamoto
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Rational design of a covalent ACE2 decoy receptor that broadly neutralizes SARS-CoV-2 variants.
Journal: Protein science : a publication of the Protein Society
Published: July 29, 2025
Evolutionary dynamics of heparan sulfate utilization by SARS-CoV-2.
Journal: mBio
Published: June 23, 2025
Legionella employs the multimodal ubiquitination of Sec22b to modulate SNARE pairing.
Journal: iScience
Published: February 23, 2025
Engineered ACE2 decoy in dry powder form for inhalation: A novel therapy for SARS-CoV-2 variants.
Journal: Molecular therapy. Methods & clinical development
Published: November 12, 2024
In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection.
Journal: Molecular therapy. Nucleic acids
Published: October 15, 2024
Selective TLR ligand stimulation enhances in vivo mosquito-borne flavivirus pathogenicity.
Journal: Cell reports
Published: October 10, 2024
Fecal fatty acid-linked bile acid profiles in pediatric patients with ulcerative colitis.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: October 08, 2024
Enterovirus 3A protein disrupts endoplasmic reticulum homeostasis through interaction with GBF1.
Journal: Journal of virology
Published: June 21, 2024
Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage.
Journal: Microbiology spectrum
Published: February 28, 2024
Last Updated: 09/26/2026